Jb Chemicals And Pharma
J.B. Chemicals and Pharmaceuticals Ltd., commonly referred to as J.B. Pharma, is a prominent player in the pharmaceutical industry, headquartered in Mumbai, India. Established in 1976, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). With a strong presence in both domestic and international markets, J.B. Pharma focuses on therapeutic areas such as cardiology, gastroenterology, and anti-infectives. The company is renowned for its commitment to quality and innovation, which has positioned it as a trusted name in the industry. Notable achievements include a robust portfolio of over 100 products and a growing footprint in various global markets, underscoring its reputation as a reliable partner in healthcare solutions.
DitchCarbon Score
How does Jb Chemicals And Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jb Chemicals And Pharma's score of 33 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jb Chemicals And Pharma's reported carbon emissions
In 2023, Jb Chemicals and Pharma reported total carbon emissions of approximately 136,837,630 kg CO2e, with emissions distributed across Scope 1 (10,097,000 kg CO2e), Scope 2 (38,981,000 kg CO2e), and Scope 3 (136,837,630 kg CO2e). This marked a significant increase in emissions compared to previous years, reflecting the company's growth and operational expansion. In 2022, the company recorded total emissions of about 159,450,30 kg CO2e, with Scope 1 emissions at 7,638,040 kg CO2e and Scope 2 at 8,306,990 kg CO2e. The trend shows a gradual decrease in Scope 1 and Scope 2 emissions from 2020, where total emissions were approximately 18,250,190 kg CO2e, comprising 8,947,450 kg CO2e from Scope 1 and 9,302,740 kg CO2e from Scope 2. Despite the increase in total emissions in 2023, Jb Chemicals and Pharma has not publicly disclosed specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of documented reduction targets suggests a need for enhanced climate commitments within the industry context. As the pharmaceutical sector faces increasing scrutiny regarding sustainability practices, Jb Chemicals and Pharma's future strategies will be crucial in addressing climate change and reducing emissions effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 8,691,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 45,030,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jb Chemicals And Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
